Background-Microsomal (m) prostaglandin (PG) E 2 synthase (S)-1 catalyzes the formation of PGE 2 from PGH 2 , a cyclooxygenase product that is derived from arachidonic acid. Previous studies in mice suggest that targeting mPGES-1 may be less likely to cause hypertension or thrombosis than cyclooxygenase-2-selective inhibition or deletion in vivo. Indeed, deletion of mPGES-1 retards atherogenesis and angiotensin II-induced aortic aneurysm formation. The role of mPGES-1 in the response to vascular injury is unknown. Methods and Results-Mice were subjected to wire injury of the femoral artery. Both neointimal area and vascular stenosis were significantly reduced 4 weeks after injury in mPGES-1 knockout mice compared with wild-type controls (65.6Ϯ5.7 versus 37.7Ϯ5.1ϫ10 3 pixel area and 70.5Ϯ13.4% versus 47.7Ϯ17.4%, respectively; PϽ0.01). Induction of tenascin-C, a proproliferative and promigratory extracellular matrix protein, after injury was attenuated in the knockouts. Consistent with in vivo rediversion of PG biosynthesis, mPGES-1-deleted vascular smooth muscle cells generated less PGE 2 but more PGI 2 and expressed reduced tenascin-C compared with wild-type cells. Both suppression of PGE 2 and augmentation of PGI 2 attenuate tenascin-C expression and vascular smooth muscle cell proliferation and migration in vitro. Conclusions-Deletion of mPGES-1 in mice attenuates neointimal hyperplasia after vascular injury, in part by regulating tenascin-C expression. This raises for consideration the therapeutic potential of mPGES-1 inhibitors as adjuvant therapy for percutaneous coronary intervention. (Circulation. 2011;123:631-639.)
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Microsomal (m) PGE synthase (S)-1, which catalyzes the isomerization of PGH 2 , into PGE 2 , has emerged as an alternative drug target to COX-2. [5] [6] [7] Two other PGE synthases have been identified, mPGES-2 8 and cytosolic PGES. 9,10 mPGES-1, however, is the dominant source of PGE 2 biosynthesis, at least under basal conditions and in inflammatory syndromes in mice. 11 Targeting of mPGES-1 may be less likely to cause hypertension or thrombosis than COX-2-selective inhibitors in vivo. 11, 12 Although this distinction may not be absolute, 13 deletion of mPGES-1 also retards atherogenesis 14 and attenuates angiotensin II-induced abdominal aortic aneurysm formation in low density lipoprotein receptor null (LDLR Ϫ/Ϫ ) mice. 15 COXs and PGs differentially modulate the response to vascular injury. For example, wire-induced vascular proliferation is enhanced in mice that are genetically deficient in the PGI 2 receptor (IP), whereas deletion of the thromboxane A 2 receptor depresses this response. 16 Despite the association of purposefully designed COX-2 inhibitors with a cardiovascular hazard, there are conflicting reports of the impact of disrupting this pathway on vascular remodeling. For example, pharmacological suppression of COX-2-derived PGI 2 pro-motes adverse vascular remodeling in a flow-induced injury model, an effect replicated by deletion of the IP. 17 However, celecoxib, with presumed inhibition of the same pathway, reduces neointimal hyperplasia in balloon-injured carotid arteries in rats and rabbits. 18, 19 Furthermore, a small controlled clinical trial suggests that celecoxib reduces in-stent late luminal loss at 6 months in patients with coronary artery disease who are receiving aspirin plus clopidogrel. 20 Although Wu et al 21 found that celecoxib, but not mPGES-1 deletion increased mortality in mice after experimental myocardial infarction, Degousee et al 22 observed delayed adverse ventricular remodeling in mPGES-1 knockouts (KOs).
Tenascin-C (TN-C) is a multifunctional extracellular matrix (ECM) glycoprotein that regulates cell differentiation, 23 proliferation, 24, 25 survival, 26 and migration 27 during development and tissue remodeling. TN-C is highly expressed during embryonic branching morphogenesis and dissipated in adult lungs. 28 TN-C is re-expressed during wound healing and regeneration, as well as under pathological conditions. In the latter setting, TN-C promotes pulmonary 29 and systemic 30, 31 vascular neointimal hyperplasia by promoting vascular smooth muscle cell (VSMC) growth. In the case of pulmonary hypertension, TN-C regulates VSMC growth in part by inducing integrin-associated EGF receptor activation followed by regulation of downstream cell survival. 24 A role for PGs in the regulation of TN-C expression is suggested by earlier studies. Inhaled iloprost, a prostacyclin analog, reverses TN-C expression and vascular remodeling in experimental pulmonary hypertension in rats. 32 PGE 2 induces expression of TN-C in stromal cells of the murine uterus. 33 Matrix metalloproteinases upregulate TN-C by generating ␤3 integrin ligands in type I collagen, 26 whereas mPGES-1 promotes vascular matrix metalloproteinase-2 activity in a vascular inflammatory condition, aortic aneurysm. 15 Here, we demonstrate that deletion of mPGES-1 in mice attenuates neointimal hyperplasia after vascular injury. Both suppression of PGE 2 and rediversion of the accumulated PGH 2 substrate to PGI 2 may contribute to impaired VSMC proliferation, dysregulated expression of TN-C expression, and impaired VSMC migration in the KOs. These studies indicate a potential utility of targeting mPGES-1 in percutaneous coronary intervention.
Methods

Mice and the Vascular Injury Model
mPGES-1 KOs and their wild-type (WT) controls were generated by corresponding homozygous breeders derived from mPGES-1 ϩ/Ϫ mice, which are backcrossed to C57B6 for 7 generations from the original mPGES-1 Ϫ/Ϫ mice, which were a kind gift from Pfizer. 6 The femoral artery wire injury was performed as previously described 34 with modifications. Briefly, 1 side of the femoral artery was exposed by blunt dissection while mice were under anesthesia. The accompanying femoral nerve and femoral vein were carefully separated from the artery. The femoral artery was looped proximally and distally with 6 -0 silk suture for temporary blood flow cessation during the procedure. A small branch between the rectus femoris and vastus medialis muscles was isolated; a transverse arteriotomy was performed in the branch; and a flexible angioplasty wire (0.35-mm diameter; Cook Inc, Bloomington, IN) was inserted into the femoral artery for Ͼ5 mm toward the iliac artery. The wire was left in place for 3 minutes to denude and dilate the artery. Then, the wire was removed, and the silk suture looped at the proximal portion of the muscular branch artery was secured. Blood flow in the femoral artery was restored by releasing the sutures, and the skin incision was closed with a 5-0 silk suture. The femoral artery on the other side was sham-operated and served as a control. Alzet osmotic minipumps (model 2002, Alza Scientific Products, Palo Alto, CA) were placed subcutaneously via a midback incision and loaded with Figure 1 . Deletion of mPGES-1 reduced neointimal formation. Neointimal area (A), the ratio of intima to media (B), and stenosis (C) were reduced significantly in mPGES-1 KO mice compared with WT controls. *PϽ0.05; **PϽ0.01. nϭ4 per group for sham-operated animals; nϭ13 for WT injured animals; nϭ12 for KO injured animals. D, Representative hematoxylin and eosin staining of cross sections from sham-operated or wire-injured arteries. N denotes neointima; M, media; Š, internal elastin; and ‹, external elastin. Scale barϭ20 m.
bromodeoxyuridine (BrdU; Sigma-Aldrich, St Louis, MO) to deliver 25 mg ⅐ kg Ϫ1 ⅐ d Ϫ1 . Twenty-eight days after injury, animals were euthanized and perfused with 0.9% NaCl followed by Prefer (Anatech, Battle Creek, MI). Femoral arteries were harvested and embedded in paraffin for morphometric or histological analysis. All animals were housed according to guidelines of the Institutional Animal Care and Use Committee of the University of Pennsylvania, and all experiments were approved by that committee.
Biochemical, Molecular, and Cellular Methods
PGs or metabolites were determined with ultraperformance liquid chromatography-tandem mass spectrometry as previously described. 15, 35 The ultraperformance liquid chromatography column used was a Hypersil GOLD, 200ϫ2.1 mm, with a particle size of 1.9 m (Thermo Scientific, West Palm Beach, FL), which allows distinction of the authentic peak of 2,3-dinor-6-keto PGF 1␣ from an endogenous peak of unknown identity at the specified ion transition. VSMCs were isolated from the aortas of WT, mPGES-1, or IP KO mice 16 as previously described, 14 and only VSMCs below passage 5 were used. For RNA interference studies, VSMCs were trypsinized and reseeded (7.5ϫ10 5 cells per 100-mm dish) in media without antibiotics overnight. The next day, lipofectamine 2000 (1 L per 25 000 cells; Invitrogen, Carlsbad, CA) and TN-C small interfering RNA (siRNA; Ambion ID s75240; 100 nmol/L) or control siRNA (ID65306 D-00121002Ј; Dharmacon Inc, Lafayette, CO) were diluted in Opti-MEM (Invitrogen) and added to the cells for 4 hours before the cells were switched to fresh serum-containing media overnight. 36 VSMCs (70% to 80% confluent) were then seeded onto 35-mm-diameter dishes containing autoclaved glass coverslips; after attachment, they were serum starved for 48 hours and then stimulated with 2% FBS for 48 hours in the presence or absence of PGE 2 or an IP agonist or IP antagonist before analysis for BrdU incorporation. BrdU incorporation was determined as described previously. 37 Migration studies and TN-C staining were carried out 60 hours after siRNA transfection with overnight serum starvation.
Morphometry and Histology
Cross sections of the injured arteries of individual animals were serially obtained at 10 levels from the distal branch point of the femoral artery at 140-m intervals (8 levels were sectioned for assessment of early cell infiltration/migration) and were stained with hematoxylin and eosin. Images were acquired with a charge-coupled device camera coupled to an inverted Nikon E600 microscope. Images were then digitized with Image Pro software (Media Cybernetics, Silver Spring, MD). Morphometric analysis was performed with a customized program (Phase 3 Imaging Systems, Glen Mills, PA) of Image Pro to measure the area of the lumen, the area inside the internal elastic lamina, and the area inside the external elastic lamina. This system was also used to count BrdU-labeled cells within the media and intima of vessels. Percentage stenosis was calculated as the ratio of the intimal area to the area inside the original internal elastic lamina, and the ratio of intima to media was determined. Sections with the maximal lesion area were selected to represent the animal from which femoral arteries had been harvested. Histology staining is detailed in the online-only Data Supplement.
Measurements of Cell Motility
Cell motility was studied by posthoc analysis of movies that record cell behavior after seeding onto thin film of fibrillar type I collagen, prepared as described previously. 38 Neutralized collagen solutions were applied to flat-bottom, non-tissue-cultured-treated polystyrene plates (BD Biosciences, San Jose, CA) and then placed at 37°C overnight to initiate fibrillogenesis. After incubation, the gelled collagen film (monolayer) was rinsed with PBS (Ϸ10 times) and deionized water (Ϸ10 times). Samples were then dried under a stream of filtered N 2 and immediately placed back into a PBS solution. Such prepared collagen films have increased rigidity, which can cause cells to assume a proliferative phenotype, mimicking an injured state in vivo. 39 Twenty-four hours before the experiments, cells were treated with complete medium containing 2% FBS. Before seeding, cells were trypsinized with 0.25% trypsin-EDTA (Gibco BRL, Invitrogen Corp) and seeded in 0.5 mL of 2% FBS medium at a density of 2ϫ10 4 cells per well (Ϸ5000 cells/cm 2 ). Recording of cell motility was started 10 minutes after seeding to allow the setting of the microscope. Three or 4 fields of view (movies) were recorded for SMCs from each animal, and 2 animals of each genotype were used.
The live cell culture imaging system consists of a custom-made biochamber with humidified atmosphere at 37°C with 5% CO 2 incorporating a digitalized controlled x-y-z motorized stage driven by a stepper motor drive systems mounted on an inverted microscope (Nikon TE 2000-U, Nikon, Tokyo, Japan). Images were acquired with a high-resolution cooled charge-coupled device camera (Photometrics Ropert Scientific, Tucson, AZ) at 5-minute intervals over 24 hours with a ϫ10 phase-contrast objective lens. Image sequences were processed with Nikon Elements Software (version 3.0; Nikon), converted to an 8-bit image, and enhanced for contrast and brightness with Image J software (version 1.38x; National Institutes of Health, Bethesda, MD). The percentage of spreading cells at a given time point after cell seeding was calculated from the movies. Five cells per movie were randomly chosen for velocity calculation, with the only criterion being that cells should be within an observation frame from recording start till the end. The center point of the selected cells, ie, the average of the x and y coordinates of all of the Cell motility was also studied by both a scratch wound healing assay and a transwell assay. VSMCs were plated for 24 hours in complete media and were then serum starved overnight before the monolayer was scratched with a pipette tip for the scratch wound healing assay. Cell motility was recorded as described above every 30 minutes for 24 hours, and serial images were converted to TIFF and MPEG movie formats for analysis. The distance cells traveled between the time when the surface was scratched and 24 hours later was measured (nϭ5 cells per field, repeated 3 times per experiment setting). The transwell assay was used to examine effects of supplementing exogenous TN-C on SMC migration. Transwell plates (8-m pore size; Corning Inc, Corning, NY) were coated with 50 L PBS-reconstituted 20 g/mL TN-C (Millipore Corp, Temecula, CA) on both sides at 37°C for 1 hour. Serum-starved SMCs were seeded to the upper chamber at 10 000 per well in media with 2% serum. Twenty-four hours later, cells were fixed with Prefer for 5 minutes. Nonmigrated cells on the upper well side of the membrane were gently wiped off with a cotton stick; the membrane was removed and stained with DAPI; and the migrated cells were counted with high-power magnification (ϫ20) for 10 fields with a fluorescent microscope. The average cell number of the 10 fields was used to represent an individual transwell reading.
Statistical Analysis
Data are expressed as meanϮSEM unless indicated otherwise. Comparisons of multiple groups were performed by ANOVA, and when only 2 mean values were compared, the 2-tailed t test was used. Bonferroni correction or the Dunnett test was applied when appropriate as indicated in the text. In all cases, statistical significance was defined as PϽ0.05.
Results
Deletion of mPGES-1 Reduces Neointimal Hyperplasia in the Wire-Injured Femoral Artery
To examine the role of mPGES-1 in vascular remodeling, mice were subject to endothelial denudation by wire injury to the femoral artery and were examined 28 days later. Injured vessels from mPGES-1-deficient mice show reduced neointimal formation, a reduced intima-to-media ratio, and less stenosis ( Figure 1A through 1D) . Furthermore, the percentage of proliferating cells detected after BrdU incorporation was also reduced in the KOs (102Ϯ17 versus 50Ϯ12 cells per cross section). mPGES-1 was expressed in medial VSMCs and in the endothelium and perivascular region within the injured vessel in WT mice ( Figure I in the online-only Data Supplement). Cellular infiltration/migration to the subendothelium was also limited by mPGES-1 deletion 7 days after the injury ( Figure II in the online-only Data Supplement).
Vascular injury resulted in a procedure-related increase in PG biosynthesis. Deletion of mPGES-1 significantly reduced synthesis of PGE 2 while augmenting the endoperoxide rediversion products, PGI 2 and PGD 2 . This contrast in product formation was even more pronounced when WT and KO mice were subject to injury. In that setting, formation of thromboxane was also augmented in the KOs (Figure 2 and Figure III in the online-only Data Supplement).
mPGES-1 Deletion Modulates TN-C Expression and VSMC Migration
Expression of TN-C was upregulated in medial and neointimal VSMC layers in response to injury, and this response was attenuated by mPGES-1 deletion ( Figure 3A) . Consistent with these in vivo studies, mPGES-1 deletion also reduced TN-C expression in cultured VSMCs ( Figure 3B) .
Formation of the 2 most abundant prostanoids formed by VSMCs, PGE 2 and PGI 2 , was differentially regulated by mPGES-1 deletion in vivo, and a similar divergent pattern of formation was observed in VSMCs cultured ex vivo ( Figure  3C ). Here, we failed to detect the production of PGD 2 by VSMCs, and the trivial amounts of thromboxane formation were unaltered by gene deletion (data not shown). Treating WT VSMCs with PGE 2 at 28 or 280 nmol/L slightly increased TN-C expression. In contrast, the IP agonist iloprost 40 strikingly decreased TN-C expression at the same concentrations ( Figure 3B and data not shown) . Cicaprost, 11 another IP agonist, also dose-dependently suppressed TN-C Figure 4 . Impaired motility in mPGES-1 Ϫ/Ϫ VSMCs. VSMC motility was examined for 24 hours after plating VSMCs on collagen thin films, as detailed in Methods. Seven or 8 movies were recorded for WT or mPGES-1 KO cells that were isolated from 2 animals of each genotype. A, VSMC velocity was decreased in mPGES-1 KOs. Distance traveled between each current time point and the immediate past time point was used to calculate velocity at individual time points. The Fisher combined P value is 0.0128 for the two 2-way ANOVA P values coming from each of the 2 WT/KO pairs. The scratch wound healing assay (B) also shows that mPGES-1 KO cells (bottom) migrated more slowly than WT VSMCs (top). The photos shown were taken at baseline (0 hours) and 24 hours after wounding, and the dotted line and solid lines demark the starting and ending edge of cells, respectively, during the 24-hour scratch healing process. C, Knockdown TN-C with siRNA results in an impaired healing process. Representative graphs of 3 independent studies with triplicate treatments in each study are shown (B and C). D, TN-C partially rescues the impaired migration of mPGES-1 KO VSMCs. The migration assay was conducted as detailed in Methods, with a transwell plate that was precoated with or without TN-C. **PϽ0.01. nϭ4. Data presented are representative of 3 independent experiments. expression ( Figure 3D) . Thus, the increased levels of PGI 2 may substantially contribute to the suppression of TN-C in mPGES-1 KO SMCs.
Increased expression of TN-C after injury provides a scaffold on which VSMCs may migrate in the process of neointima formation. 41 Consistent with the restraint in expression of TN-C, migration of mPGES-1 KO VSMCs on a collagen-coated surface was impaired ( Figure 4A 
Differential Regulation of VSMC Cell Cycle by PGs in mPGES-1 KOs
VSMC proliferation was also influenced by mPGES-1 deletion. S-phase entry was suppressed in VSMCs cultured from KOs ( Figure 6A and 6B) . PGE 2 dose-dependently promoted proliferation and rescued this phenotype ( Figure 6A ). PGE 2 similarly affected proliferation in both WT and IP KO SMCs ( Figure 6B ) without changing PGI 2 release into the media (data not shown), indicating that the proliferative effect of PGE 2 does not depend on signaling via the IP. On the other hand, cicaprost inhibits S-phase entry in WT VSMCs, whereas CAY10441, 43 an IP antagonist, promotes this phenomenon ( Figure 6A ). Thus, both suppression of PGE 2 and augmentation of PGI 2 may contribute to the restraint on injury-induced VSMC proliferation observed in mPGES-1 KOs.
Discussion
The role of COX-2 inhibition and mPGES-1 deletion in cardiovascular remodeling is complex. Although COX-2 inhibition restrains neointima formation in response to wire or balloon vascular injury, 18, 19 it exacerbates the remodeling response to restriction of blood flow in ligated arteries. 17 Although global mPGES-1 deletion, unlike COX-2 inhibition, does not increase mortality after coronary artery ligation in mice, 21 it does adversely influence myocardial remodeling. 22 Here, we report that, in contrast, the vascular remodeling response to injury is restrained in mPGES-1-deficient mice. Although the mechanistic distinctions that account for this phenotypic divergence in mPGES-1 KOs are currently unclear, they likely reflect 2 fundamental properties: the contrasting biological responses evoked by prostanoids and the contrasting predominant products of substrate rediversion products of mPGES-1 deletion in distinct cell types. 14 Furthermore, despite mPGES-1 deletion, PGE 2 formation is actually sustained in the peri-infarct myocardium as a result of infiltration of myeloid cells expressing alternate PGES enzymes, 22 whereas in the setting of vascular injury, biosynthesis of PGE 2 and its formation by VSMC are suppressed.
Intimal hyperplasia is a feature of vascular remodeling caused by either injury or changes in blood flow. It is characterized by abnormal migration and proliferation of SMCs coincident with de novo deposition of the surrounding ECM. 41 TN-C, an ECM glycoprotein, is upregulated during neointimal hyperplasia and associated with the synthetic proliferative phenotype of VSMCs after balloon injury, 44 in pulmonary hypertension, 24 and in vascular grafting. 30, 45 It may provide a scaffold along which proliferating VSMCs can migrate to form the neointima. Interestingly, TN-C is subject to regulation by PGs in this study and others. 32, 33 Thus, TN-C constitutes a focus for mechanistic elucidation of mPGES-1-modulated vascular remodeling. We have demonstrated that the deletion of mPGES-1 attenuates upregulation of TN-C in response to injury and that knockdown of TN-C impairs VSMC migration in vitro. In VSMCs, the dominant effect of mPGES-1 deletion on VSMC PG formation is to depress PGE 2 and to augment PGI 2 . Cicaprost, a highly selective PGI receptor agonist, dose-dependently downregulates TN-C expression in VSMCs, whereas PGE 2 slightly upregulates TN-C. In this study, we show that these prostanoids have contrasting effects on TN-C expression and thus may have contributed to the impact of mPGES-1 on VSMC migration and proliferation. It is possible that mPGES-1 deletion may regulate expression of other ECM molecules besides TN-C, which may mediate VSMC behavior. Global production of ECM was examined, as reflected by trichrome stain ( Figure  VI in the online-only Data Supplement). ECM was increased by injury in both WT arteries and mPGES-1 KOs; however, the composition of ECM cannot be identified by this approach and awaits elucidation.
Deletion of mPGES-1 also suppresses VSMC proliferation in response to vascular injury. This response is mimicked by knockdown of TN-C ( Figure VII in the online-only Data Supplement). As with VSMC migration, the effects of mPGES-1 deletion on both PGE 2 and PGI 2 may have been relevant. Thus, PGE 2 dose-dependently restores impaired proliferation of mPGES-1 in mPGES-1 KOs. In contrast, activation of the IP by cicaprost suppresses proliferation in both WT and KO VSMCs. Thus, both depression of PGE 2 and augmented formation of PGI 2 may have contributed to the suppression of VSMC proliferation in mPGES-1 KO mice.
These studies raise the possibility of mPGES-1 inhibition as a strategy to limit restenosis after percutaneous coronary intervention. However, a limitation may prove to be the contrasting effect on myocardial remodeling after coronary ligation. 22 Despite the risk of myocardial infarction conferred by celecoxib in placebo-controlled trials, [1] [2] [3] preliminary evidence suggests that in patients receiving platelet inhibitors to limit this risk, restenosis might be reduced by this purposely designed NSAID selective for inhibition of COX-2. 20 Whereas mPGES-1 inhibitors might be expected to confer a diminished risk of myocardial infarction compared with COX-2 inhibitors, 11 the comparative safety and efficacy of these compounds in the setting of percutaneous coronary intervention remain to be determined.
Conclusions
Deletion of mPGES-1 decreases vascular injury-induced VSMC proliferation, in part by regulating TN-C expression and subsequent neointimal hyperplasia. Both suppression of PGE 2 and augmented formation of PGI 2 may contribute to these effects. The therapeutic potential of locally delivered mPGES-1 inhibitors as an adjuvant for percutaneous coronary intervention merits further consideration.
